Mydecine Innovations Group (MYCO.C) announced that they have received approval from Health Canada to significantly expand their cultivation capacity at their Canadian Current Good Manufacturing Practice (cGMP) facility at…
Psychedelics
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…
In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…
Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
Novamind (NM.C) announced that they have opened a new Novamind Client Care Center to manage the “overwhelming demand for its treatments”. The new client care center is located in…
Lobe Sciences (LOBE.C) entered into a production and supply agreement with psychedelics biotech company, HAVN Life Sciences (HAVN.C) today, for their Vitamind line of functional mushrooms, according to a…
They seem to have been born that way. They are naturally incapable of grasping and developing a manner of living which demands rigorous honesty. Today Alcoholics Anonymous (AA) is…
Cybin (CYBN.NE) announced that the Institutional Review Board (IRB) has granted them approval to begin the study of its sublingual psilocybin formulation, CYB001, in a Phase II clinical trial…
Survivors of childhood trauma Everyone’s therapy journey is different. Some people can move past what they are dealing with purely through talk therapy. By understanding on a logical level…